Umesh Gangishetti
Affiliations: | Emory University of Medicine, USA |
Area:
NeuroDegenerative diseasesGoogle:
"Umesh Gangishetti"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wharton W, Kollhoff AL, Gangishetti U, et al. (2019) IL-9 alterations linked to Alzheimer's disease in African Americans. Annals of Neurology |
| Hu WT, Howell JC, Ozturk T, et al. (2019) CSF Cytokines in Aging, Multiple Sclerosis, and Dementia. Frontiers in Immunology. 10: 480 |
| Wharton W, Kollhoff AL, Gangishetti U, et al. (2019) O2-02-01: DIFFERENT CSF TOTAL AND PHOSPHORYLATED TAU, BUT NOT Aβ, IN OLDER AND YOUNGER AFRICAN AMERICANS AND WHITES Alzheimer's & Dementia. 15: P535-P535 |
| Hu WT, Wharton W, Kollhoff AL, et al. (2019) P3-620: IL-9 ALTERATIONS ARE LINKED TO ALZHEIMER'S DISEASE IN AFRICAN AMERICANS Alzheimer's & Dementia. 15: P1214-P1214 |
| Gangishetti U, Christina Howell J, Perrin RJ, et al. (2018) Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease. Alzheimer's Research & Therapy. 10: 98 |
| Kamara DM, Gangishetti U, Gearing M, et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. Journal of Alzheimer's Disease : Jad |
| Gangishetti U, Perrin RJ, Arnold SE, et al. (2017) VALIDATING NON-AMYLOID, NON-TAU CSF BIOMARKERS FOR ALZHEIMER'S DISEASE IN THE PRE-SYMPTOMATIC, MCI, AND DEMENTIA STAGES: A MULTI-CENTER STUDY Alzheimer's & Dementia. 13: P1513-P1514 |